![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/08/05/2924178/0/en/iTeos-Therapeutics-Announces-Appointment-of-David-Feltquate-as-Chief-Medical-Officer.html
https://www.globenewswire.com/news-release/2024/07/08/2909486/0/en/iTeos-Announces-First-Patient-Dosed-in-GALAXIES-Lung-301-Phase-3-Study-Earning-35-Million-in-Milestones-from-GSK.html
https://www.globenewswire.com/news-release/2024/06/17/2899687/0/en/iTeos-and-GSK-Initiate-GALAXIES-Lung-301-Phase-3-Study-Assessing-Belrestotug-and-Dostarlimab-in-Previously-Untreated-Unresectable-Locally-Advanced-Metastatic-PD-L1-Selected-Non-Sma.html
https://endpts.com/iteos-to-raise-120m-xbrane-and-stada-to-out-license-lucentis-biosimilar/
https://www.globenewswire.com/news-release/2024/05/10/2879601/0/en/iTeos-Reports-First-Quarter-2024-Financial-Results-and-Provides-Business-Updates.html
https://www.globenewswire.com/news-release/2024/05/10/2879599/0/en/iTeos-Therapeutics-Announces-120-Million-Registered-Direct-Offering.html
https://www.globenewswire.com/news-release/2024/04/07/2858845/0/en/iTeos-Presents-EOS-984-Preclinical-Data-Demonstrating-Restoration-of-T-Cell-Activity-from-Adenosine-Suppression-at-the-American-Association-for-Cancer-Research-Annual-Meeting-2024.html
https://www.globenewswire.com//news-release/2024/03/06/2841268/0/en/iTeos-Appoints-Oncology-Veteran-Jill-DeSimone-to-Its-Board-of-Directors.html
https://www.globenewswire.com//news-release/2024/03/06/2841258/0/en/iTeos-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Business-Updates.html
https://www.globenewswire.com//news-release/2024/03/05/2840927/0/en/iTeos-to-Highlight-Preclinical-Data-on-First-In-Class-EOS-984-Targeting-ENT1-at-the-American-Association-for-Cancer-Research-Annual-Meeting-2024.html